secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2026-10-06T20:07:53+00:00
Accession:  0001193125-26-415560
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Bolt Biotherapeutics Amends Redwood City Lease, Pays $1.0M and Accelerates Expiration
--------------------------------------------------------------------------------

- Bolt Biotherapeutics entered a Second Amendment to its Chesapeake Master Lease with landlord HCP LS Redwood City LLC on October 1, 2026.
- The company paid $1.0 million and acknowledged HCP LS Redwood City LLC can draw the existing $1.5 million letter of credit in its entirety.
- Lease expiration is accelerated to December 31, 2027, or earlier after closing a financing or other Corporate Transaction.
- A Corporate Transaction closing would trigger an additional $4.5 million termination payment to the landlord.
- Bolt will remit 100% of sublease rent and common area maintenance payments from 800 Building subtenants to the landlord.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000119312526415560/0001193125-26-415560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000119312526415560/bolt-20261001.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-415560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer